SSA
BFRI icon

Schonfeld Strategic Advisors’s Biofrontera BFRI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,425
Closed -$46K – 1789
2023
Q2 		$46K Sell
4,425
-20
-0.4% -$212 ﹤0.01% 1820
2023
Q1 		$54.2K Sell
4,445
-140
-3% -$2.18K ﹤0.01% 1762
2022
Q4 		$84.1K Buy
4,585
+20
+0.4% +$408 ﹤0.01% 2218
2022
Q3 		$96K Sell
4,565
-30
-0.7% -$820 ﹤0.01% 2567
2022
Q2 		$171K Buy
4,595
+130
+3% +$7.89K ﹤0.01% 1958
2022
Q1 		$298K Buy
+4,465
New +$324K ﹤0.01% 1696

Other funds holding BFRI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CSPIA
Cary Street Partners Investment Advisory Richmond, Virginia $494M AUM 27.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Schonfeld Strategic Advisors's BFRI Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of Biofrontera (BFRI) in Q3 2023, closing a stake of 4,425 shares — an estimated $46K sold.

Schonfeld Strategic Advisors first reported a position in BFRI in Q1 2022 and held it in 6 quarters. The position peaked at $298K in Q1 2022. 8 funds tracked by Wall St. Rank hold BFRI as of Q3 2023.

  • Schonfeld Strategic Advisors reported no remaining Biofrontera position as of Q3 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 4,425 Biofrontera shares in Q3 2023, an estimated $46K.
  • Schonfeld Strategic Advisors first reported a position in Biofrontera in Q1 2022 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's Biofrontera position peaked at $298K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Biofrontera as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.